On June 17, 2025, AnaptysBio, Inc. held its Annual Meeting where three directors were elected for three-year terms, KPMG was ratified as auditors, and multiple equity plan approvals were voted on with varying results. The proposals included a non-binding advisory vote on executive compensation with 17.8 million votes for, and 6.6 million against.